KM Pharmaceutical Faces Managed Stock Designation Risk as Market Cap Remains Below 20 Billion KRW for 25 Consecutive Trading Days
The KOSDAQ Market Division announced that KM Pharmaceutical's market capitalization has been below 20 billion KRW for 25 consecutive trading days as of July 1, 2026.
Current market cap stands at approximately 10.3 billion KRW based on 5,577,410 outstanding shares at a price of 1,848 KRW per share.
If the market cap remains below 20 billion KRW for five more trading days, the company may be designated as a managed stock, requiring investor caution.
[AI Summary]KM Pharmaceutical faces imminent managed stock designation due to sustained market cap deficiency, posing significant investment risk and potential trading restrictions.
KOSDAQ Filing Information
Other Market Notice (Stocks with Concern of Designation as Managed Items) (Market Capitalization Less than 20 Billion Won)